Market Tracker

03/30 4:24pm ET

Mateon Therapeutics Inc (OTCQX US:MATN.PK)

0.73
Delayed Data
As of Mar 29
 +0.01 / +1.39%
Today’s Change
0.27
Today|||52-Week Range
1.02
+101.46%
Year-to-Date
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.72
Today’s open0.73
Day’s range0.65 - 0.76
Volume47,467
Average volume (3 months)140,652
Market cap$19.4M
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)+28.00%
Earnings growth (this year)+3.70%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.76

Competitors

No competitors data available.

Financials

Last reporting dateMarch 30, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$13.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
William D. Schwieterman
Chief Financial Officer
Matthew M. Loar
Corporate headquarters
South San Francisco, California

Forecasts

Chart unavailable